Bio Techne | TECH - 债务



金融业
股票价格
USD
资产
USD 2.55B
现金及等价物
USD 264.71M
销售成本
USD 103.13M
流动资产
USD 688.05M
流动负债
USD 153.28M
债务
USD 200M
股息收益率
0.61
EBIT
USD 75.5M
EBITDA
USD 115.94M
员工
3.1K
EPS每股收益
USD 0.52
股本和储备
USD 2.09B
销售毛利
USD 222.15M
债务利息支出
USD 3.6M
利息收入
USD 981K
贷款资金
USD 200M
市值
USD 11.38B
净收入
USD 51.05M
营业费用
USD 235.92M
营业利润
USD 75.5M
普通股股本
USD 156.45M
PE价格收益
38.75
税前利润
USD 106.09M
销售收入
USD 321.2M
销售和管理费用
USD 109.34M
股票
USD 195.74M
贸易债权人
USD 95.6M
应收帐款人
USD 214.56M


债务 更改 日
Agilent USD 3.35B 0 2025-12
Becton, Dickinson and Co. USD 17.28B 2.26B 2026-03
Bio Techne USD 200M 0 2026-06
Bio-Rad Laboratories USD 1.37B 7.8M 2026-06
Bruker USD 1.82B 153.5M 2026-06
Charles River Laboratories USD 3.06B 485.84M 2026-03
Danaher USD 26.56B 8.07B 2026-06
Illumina USD 2.54B 9M 2026-03
IQVIA Holdings USD 16.24B 408M 2026-06
Merck EUR 12.04B 86M 2026-03
Mettler Toledo International USD 2.23B 76.47M 2026-03
OraSure Technologies USD 782K 465K 2024-06
Pacific Biosciences Of California USD 892.24M 653K 2023-12
Repligen USD 690.94M 144.36M 2026-06
Revvity USD 3.35B 48.03M 2026-03
Standard Biotools USD 29.49M 2.1M 2026-03
Thermo Fisher Scientific USD 43.16B 3.78B 2026-03
Waters USD 5.57B 4.08B 2026-03